Guangdong Kanghua Healthcare Co., Ltd.

SEHK:3689 Rapporto sulle azioni

Cap. di mercato: HK$819.3m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Guangdong Kanghua Healthcare Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Wangzhi Chen

Amministratore delegato

CN¥1.5m

Compenso totale

Percentuale dello stipendio del CEO85.7%
Mandato del CEO8.7yrs
Proprietà del CEOn/a
Durata media del management8.2yrs
Durata media del Consiglio di amministrazione8.7yrs

Aggiornamenti recenti sulla gestione

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Recent updates

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Jun 10
Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

May 22
Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Nov 28
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

May 09
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Feb 02
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Nov 08
Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Sep 06
Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

May 31
Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Jan 25
Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Sep 21
Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

May 03
Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Feb 04
Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Wangzhi Chen rispetto agli utili di Guangdong Kanghua Healthcare?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023CN¥1mCN¥1m

CN¥121m

Sep 30 2023n/an/a

CN¥118m

Jun 30 2023n/an/a

CN¥116m

Mar 31 2023n/an/a

CN¥89m

Dec 31 2022CN¥2mCN¥1m

CN¥60m

Sep 30 2022n/an/a

CN¥59m

Jun 30 2022n/an/a

CN¥59m

Mar 31 2022n/an/a

CN¥76m

Dec 31 2021CN¥2mCN¥1m

CN¥94m

Sep 30 2021n/an/a

CN¥103m

Jun 30 2021n/an/a

CN¥112m

Mar 31 2021n/an/a

CN¥43m

Dec 31 2020CN¥2mCN¥2m

-CN¥25m

Sep 30 2020n/an/a

-CN¥63m

Jun 30 2020n/an/a

-CN¥100m

Mar 31 2020n/an/a

-CN¥13m

Dec 31 2019CN¥2mCN¥2m

CN¥74m

Sep 30 2019n/an/a

CN¥112m

Jun 30 2019n/an/a

CN¥150m

Mar 31 2019n/an/a

CN¥159m

Dec 31 2018CN¥2mCN¥2m

CN¥168m

Sep 30 2018n/an/a

CN¥169m

Jun 30 2018n/an/a

CN¥170m

Mar 31 2018n/an/a

CN¥163m

Dec 31 2017CN¥1mCN¥792k

CN¥157m

Compensazione vs Mercato: La retribuzione totale di Wangzhi ($USD 205.96K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 235.43K ).

Compensazione vs guadagni: La retribuzione di Wangzhi è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Wangzhi Chen (53 yo)

8.7yrs

Mandato

CN¥1,470,000

Compensazione

Mr. Wangzhi Chen is Co-Owner of Dongguan Xingda Property Investment Co., Ltd. Mr. Chen serves as Chief Executive Officer of Guangdong Kanghua Healthcare Co., Ltd. Mr. Chen has been Executive Director at Gu...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Junyang Wang
Executive Chairman of the Board8.7yrsCN¥180.00k66.54%
CN¥ 545.1m
Wangzhi Chen
CEO & Executive Directorno dataCN¥1.47mNessun dato
Wai Hung Wong
Executive Vice Chairman8.7yrsCN¥180.00kNessun dato
Aiqin Wang
Executive Directorno dataCN¥303.00kNessun dato
Wai Hang Wong
CFO, Joint Company Secretary & Secretary to the Board8.7yrsNessun datoNessun dato
Baizhi Wang
Vice General Manager of Operation8.2yrsNessun datoNessun dato
Hing Ling Chau
Joint Company Secretary8.2yrsNessun datoNessun dato
Li Chen
Financial Controller8.2yrsNessun datoNessun dato

8.2yrs

Durata media

48.5yo

Età media

Gestione esperta: Il team dirigenziale di 3689 è esperto e expertise (durata media dell'incarico 8.2 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Junyang Wang
Executive Chairman of the Board8.7yrsCN¥180.00k66.54%
CN¥ 545.1m
Wangzhi Chen
CEO & Executive Director8.7yrsCN¥1.47mNessun dato
Wai Hung Wong
Executive Vice Chairman8.7yrsCN¥180.00kNessun dato
Aiqin Wang
Executive Director8.7yrsCN¥303.00kNessun dato
Keji Chen
Independent Non-Executive Director8.2yrsCN¥120.00kNessun dato
Sing Nun Chan
Independent Non-Executive Director8.7yrsCN¥120.00kNessun dato
Yubo Lv
Non-Executive Director8.2yrsNessun datoNessun dato
Ming Lai Yeung
Independent Non-Executive Director8.2yrsCN¥120.00kNessun dato
Shaoming Chen
Chairman of the Supervisory Committee8.7yrsNessun datoNessun dato
Shaofeng Wang
Member of Supervisory Committee8.7yrsNessun datoNessun dato
Chunyang Yue
Member of Supervisory Committee5.8yrsNessun datoNessun dato

8.7yrs

Durata media

49yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 3689 sono considerati esperti (durata media dell'incarico 8.7 anni).